通过新的配方-微分离方法,增强了对指甲的特比纳局部输送
Camila de Almeida Perez Pimenta1, Juliana Kishishita1, Yohana Souza Silva1
1Department of Pharmaceutical Sciences, Center for Pharmaceutical and Cosmetic Development (NUDFAC), Federal University of Pernambuco (UFPE), Recife 50740-521, PE, Brazil.
Journal of pharmaceutical sciences
|September 18, 2025
概括
改善局部抗真菌指甲的输送需要克服指甲板.
科学领域:
- 制药科学 制药科学
- 皮肤病学 皮肤病学
- 生物材料科学 生物材料科学
背景情况:
- 局部抗真菌指甲配送面临挑战,因为通过厚厚的质指甲板的透性较差.
- 现有的商业产品具有有限的活性负载 (1%的terbinafine).
研究的目的:
- 为了增强terbinafine输送到和通过指甲板.
- 研究将体力增强方法与新型特比纳配方相结合的疗效.
主要方法:
- 开发了具有较高药物负载 (2-7%) 的新型特比纳配方 (微乳液,液晶,热凝).
- 使用的身体增强技术:指甲微孔和微通道.
- 使用人工膜和人体指甲进行了体外释放和透研究.
- 对T. rubrum和C. parapsilosis进行了微生物学测试.
主要成果:
- 微孔和微通道显著增加了terbinafine的吸收到指甲和传递给受体.
- 在新型配方中实现了更高的药物负载 (高达7%).
- 微乳液配方ME5 (7%的特比纳) 显示出优异的透性和抗真菌活性.
- 即使降低了药物应用剂量,也观察到增强的分娩效果.
结论:
- 将物理指甲增强技术与先进的特比纳配方相结合,可以改善 ungual 药物输送.
- 基于微乳液的新型系统显示出治疗指甲真菌感染的巨大潜力.
- 这些发现支持开发创新的指甲药物输送系统.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
188
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
188
Bioavailability Enhancement: Drug Solubility Enhancement
223
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
223
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
189
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
189
Non-Oral Extravascular Drug Absorption Routes
490
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
490


